新型多巴胺D2和D3受体配体中的芳香链路变异
Cristian Di Biase1, Luisa Leitzbach1, Annika Frank1
1Institute of Pharmaceutical and Medicinal Chemistry, Heinrich Heine University Düsseldorf, Duesseldorf, Germany.
研究人员修改了抗精神病的结构,以创建新的多巴胺D2和D3受体连接体. 化合物6c表现出最高的亲和力,作为新型抗精神病药物开发的有希望的头.
科学领域:
- 药用化学 医学化学
- 神经药理学神经药理学
- 药物发现 药物发现 药物发现
背景情况:
- 多巴胺D2类受体 (D2R和D3R) 是抗精神病药物的关键标.
- 现有的抗精神病药物通常具有氨基和基类组之间的异形链接器.
研究的目的:
- 设计和合成新的多巴胺D2和D3受体配体.
- 探索修改链接器结构对受体亲和力的影响.
- 确定用于抗精神病药物开发的新化合物.
主要方法:
- 合成了18种新的基于甲基和甲基链接器的配体.
- 在实验室中使用放射性连接体位移测试进行评估.
- 对D2R和D3R的结合亲和度 (pK_i) 的确定.
主要成果:
- 所有合成的配体都对D2R和D3R表现出适度的纳米分子亲和力.
- 化合物6c,N-(4-{2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl}phenyl) 乙胺,显示了最高的亲和力.
- 化合物6c的pK_i值为D2R的7.83和D3R的8.04,对D3R有轻微的偏好.
结论:
- 在抗精神病支架中修改异质链接器可以产生强大的D2/D3受体连接体.
- 化合物6c代表了开发新的D2R和D3R向剂的有价值的参考结构.
- 这项研究为新一类抗精神病药物候选药物提供了基础.
更多相关视频
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
07:25Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology
Published on: March 27, 2018
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Antipsychotic Drugs: Typical and Atypical Agents
Drugs Affecting Neurotransmitter Synthesis
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
